INBIO
LIVE

Serial Number

97789787

Owner

Indoor Biotechnologies, Inc.

Attorney

Michael J. Hertz

Filing Date

Feb 10, 2023

Add to watchlist:

No watchlists yet
View on USPTO

INBIO Trademark

Serial Number: 97789787 • Registration: 7425167

INBIO is a trademark filed by Indoor Biotechnologies, Inc. on February 10, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Indoor Biotechnologies, Inc. (6 trademarks)

Charlottesville, VA 22903

Entity Type: 03

Trademark Details

Filing Date

February 10, 2023

Registration Date

June 25, 2024

Published for Opposition

April 9, 2024

Goods & Services

Education services, namely, providing training courses in the fields of allergy, immunology and life sciences

Medical diagnostic assay preparations for testing of body fluids; medical diagnostic reagents and assays for testing body fluids, composed of antibodies for detection of antibodies in blood and other body fluids; diagnostic kits consisting primarily of antibodies, buffers and reagents for use in disease testing, namely, for diagnosis of allergic diseases

Diagnostic assay preparations for scientific or research use; antibodies for scientific or research use or for use in the manufacture of allergen detection systems, devices and allergen purification systems; antibodies for clinical or medical laboratory use or for environmental analysis, namely, analysis of the exposure to allergens, all for use in the diagnosis of allergic diseases, including rhinitis, asthma, atopic dermatitis, food allergies and occupational allergies; biochemicals, namely, antibodies and allergens for scientific or research use; biochemicals in the nature of antibodies and allergens used in the manufacture of allergen detection systems and devices and allergen purification systems; assays for research purposes, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods or any other substances; diagnostic assays for research purposes, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods, or any other substances; diagnostic kits consisting primarily of antibodies, buffers, and reagents to monitor allergen concentrations in indoor and outdoor environments, or in dust, air, foods or any other substances, antibodies in blood and other body fluids

Providing medical information regarding the health effects of environmental allergens, molds and bacterial products, their effects on indoor air quality, associated diseases, and exposure assessment and risk factors

Medical diagnostic instruments for the analysis of body fluids, namely, diagnostic instruments composed of plastic microtiter plates, nitrocellulose membranes, affinity matrices and microbeads, for detection of antibodies in blood and other body fluids; medical apparatus and instruments, composed of plastic microtiter plates, antibody immunoadsorbents prepared using agarose beads, agarose and acrylamide gels, plastic laboratory columns and tubing, for isolation and purification of natural and recombinant allergens for diagnosis and treatment of allergic diseases; medical apparatus and instruments, composed of plastic dust collection devices with membrane filters, plastic microtiter plates, plastic cassettes containing antibody coated membranes, and dipsticks for use in diagnosis and treatment of allergic diseases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 25, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 25, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 1, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 1, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 13, 2023 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Nov 9, 2023 GPRN
PRIORITY ACTION E-MAILED
Nov 9, 2023 GPRA
PRIORITY ACTION WRITTEN
Nov 9, 2023 CPRA
ASSIGNED TO EXAMINER
Nov 8, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 2, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 1, 2023 NWOS
NEW APPLICATION ENTERED
Feb 14, 2023 NWAP